Vu Quan Anh

Reporting owner on Forms 3, 4 and 5, CIK 1892297.

Vu Quan Anh reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.

Issuers

Issuer	Roles in the latest filing	Filings	Last filed
Monopar Therapeutics CIK 1645469	officer (Chief Financial Officer)	1	2026-10-02

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

Security	Date	Code	Shares	Price	Owned after	Filing
Monopar Therapeutics Common Stock	2026-09-30	M exercised	+614		2,835	Form 4
Monopar Therapeutics Common Stock	2026-09-30	F withheld for tax	-180	$79.67	2,655	Form 4
Monopar Therapeutics Restricted Stock Unit, derivative	2026-09-30	M exercised	-614	$0	7,984	Form 4

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

Filing	Subject	Filed	Accepted	Ingested
Form 4 0001437749-26-031924	Monopar Therapeutics	2026-10-02	2026-10-02 22:14:09 UTC	2026-10-06 10:23:50 UTC